| Serial Number | 78902560 |
| Word Mark | INVOLVE IRBESARTAN IN THE EVALUATION OF THE OUTLOOK OF HIGH RISK CARDIOVASCULAR PATIENTS |
| Filing Date | Wednesday, June 7, 2006 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, November 28, 2014 |
| Registration Number | 3414637 |
| Registration Date | Tuesday, April 22, 2008 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 7, 2007 |
| Indication of Colors claimed | The color(s) blue and pink is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "IRBESARTAN IN THE EVALUATION OF THE OUTLOOK OF HIGH RISK CARDIOVASCULAR PATIENTS" |
| Description of Mark | The mark consists of the word iNVOLVE which is blue with the exception of the letter "i," which is pink. Over the iNVOLVE element there is a curved bar or line in pink. The remaining element(s) of the mark appear under the iNVOLVE element in significantly smaller size in blue. |
| Goods and Services | Clinical research in the field of hypertension and anti-hypertensive pharmaceuticals; medical and scientific research, namely, conducting clinical trials for anti-hypertensive pharmaceuticals |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, November 28, 2014 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SANOFI |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | Paris 75008 FR |
| Party Name | sanofi-aventis |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Paris 75013 FR |
| Party Name | sanofi-aventis |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Paris 75013 FR |
| Party Name | sanofi-aventis |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Paris 75013 FR |
| Event Date | Event Description |
| Friday, November 28, 2014 | CANCELLED SEC. 8 (6-YR) |
| Wednesday, March 7, 2012 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, March 7, 2012 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, June 1, 2011 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, December 23, 2010 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 22, 2008 | REGISTERED-PRINCIPAL REGISTER |
| Monday, March 17, 2008 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Friday, March 7, 2008 | NOTICE OF ALLOWANCE CANCELLED |
| Friday, March 7, 2008 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, October 30, 2007 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 7, 2007 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 18, 2007 | NOTICE OF PUBLICATION |
| Monday, July 2, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, June 29, 2007 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 26, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 26, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, June 26, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 30, 2007 | PRIORITY ACTION E-MAILED |
| Monday, April 30, 2007 | PRIORITY ACTION WRITTEN |
| Wednesday, April 25, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 25, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, April 23, 2007 | ASSIGNED TO LIE |
| Wednesday, March 21, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, September 28, 2006 | NON-FINAL ACTION E-MAILED |
| Thursday, September 28, 2006 | NON-FINAL ACTION WRITTEN |
| Thursday, September 21, 2006 | ASSIGNED TO EXAMINER |
| Tuesday, June 13, 2006 | NOTICE OF DESIGN SEARCH CODE MAILED |
| Monday, June 12, 2006 | NEW APPLICATION ENTERED IN TRAM |